Diabetes drug semaglutide, marketed as Wegovy, could also reduce risk of cardiovascular events by 20%, its manufacturer has claimed. Novo Nordisk has announced headline findings from its SELECT trial, although they have not yet been published in a peer-reviewed journal. The manufacturer said the trial achieved its primary objective of demonstrating a statistically significant reduction […]
Wegovy, one of a new class of drugs used for weight loss, reduced the risk of serious cardiac events such as heart attacks by 20% in overweight and obese adults in a large trial, according to its manufacturer. Drugmaker Novo Nordisk on Tuesday reported the results of a new study that tracked more than 17,000 adults over […]
DUBLIN, Aug. 8, 2023 /PRNewswire/ — The “United States Women Health Laboratory Testing Market by Hereditary Cancer, Reproductive Health and Infectious Diseases, Prenatal Screening and Diagnostic Testing, Region, Competition Forecast & Opportunities, 2018-2028” report has been added to ResearchAndMarkets.com’s offering. The United States Women Health Laboratory Testing Market is poised for impressive growth during the […]
Image: The miniature human heart model could potentially transform drug testing and cardiovascular research (Photo courtesy of Tissue Dynamics) Cardiovascular ailments continue to be the primary cause of death worldwide. Now, a new multi-chambered, self-regulating miniature heart model offers a promising solution for improving survival and patient outcomes. In a groundbreaking development, a collaborative team […]
Weight loss drug Wegovy cuts risk of serious heart problems, company says | The Hill Skip to content This image provided by Novo Nordisk shows packaging for the company’s Wegovy drug. (Novo Nordisk via AP) Obesity drug Wegovy cut the risk of serious heart problems by 20 percent, the manufacturer announced Tuesday, results that could […]
A new family of COVID variants is on the rise in the U.S. and abroad—one experts say is likely responsible for a rising tide of infections and hospitalizations. The World Health Organization recently designated EG.5 a “variant under monitoring” due to its steady global growth. Reports of EG.5, detected in 45 countries so far, nearly […]
Short- and long-term alcohol use has different effects on the blood. Short-term alcohol use can lead to high blood pressure and thinned blood because it hinders blood cells’ ability to clot. Long-term, excessive drinking can decrease your heart’s ability to function correctly. This article discusses the effects that alcohol has on the blood in both […]
Considering the positive data, Novo Nordisk is planning to file for Wegovy’s label expansion in both the US and the European Union (EU) in 2023. Image Credit: Maurice NORBERT / Shutterstock. Denmark-based Novo Nordisk has announced results from a Phase III cardiovascular clinical trial, where its lead obesity drug Wegovy (2.4mg subcutaneous semaglutide) showed a […]
Dive Brief: Abbott has received U.S. Food and Drug Administration clearance for a diagnostic instrument that runs complete blood counts, the company announced on Monday. The Alinity h-series system, which received a CE mark more than five years ago, pairs Abbott’s existing automated hematology analyzer and integrated slide maker and stainer. Abbott filed for 510(k) […]
Getty Images By Laura Foster Health, Science and Environment Reporter A weight-loss drug has been proven to also reduce the risk of a stroke or heart attack, according to a new trial. The makers of Wegovy say it cuts risk of a cardiovascular event in overweight people with heart disease by a fifth. The injection […]